<DOC>
	<DOCNO>NCT01295476</DOCNO>
	<brief_summary>RATIONALE : Studying sample bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study study biomarkers bone marrow sample patient T-cell acute lymphoblastic leukemia .</brief_summary>
	<brief_title>Biomarker Study Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To confirm association induction failure ( IF ) status predict previously identify 116-member genomic classifier actual induction therapy outcome observe COG study AALL0434 . - To explore whether association early relapse ( define bone marrow extramedullary relapse within 18 month diagnosis ) predict previously identify 5-member ( primary ) 57-member ( secondary ) genomic classifier , actual relapse status 18 month COG study AALL0434 . ( Exploratory ) OUTLINE : RNA cryopreserved bone marrow sample analyze gene expression microarray method . Samples compare 116-member genomic classifier .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose Tcell acute lymphoblastic leukemia Cryopreserved bone marrow Children Oncology Group ( COG ) Cell Bank patient enrol COGAALL03B1 COGAALL0434 , include follow : 30 sample patient &gt; 25 % bone marrow blast day 29 ( induction failure [ IF ] case ) Samples case bone marrow and/or CNS relapse occur within first 18 month treatment Random sample 105 nonIF case achieve remission end induction therapy ( least 18 month ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>adult acute lymphoblastic leukemia remission</keyword>
	<keyword>childhood acute lymphoblastic leukemia remission</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>T-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>T-cell childhood acute lymphoblastic leukemia</keyword>
</DOC>